322 studies found for:    Open Studies | "Liver Cirrhosis"
Show Display Options
Rank Status Study
21 Not yet recruiting A Clinical Study to Evaluate the Safety and Efficacy of Mesenchymal Stem Cells in Liver Cirrhosis
Condition: Liver Cirrhosis
Intervention: Biological: Mesenchymal stem cell
22 Recruiting Comparison of Efficacy of Cefotaxime, Ceftriaxone, and Ciprofloxacin for the Treatment of Spontaneous Bacterial Peritonitis in Patients With Liver Cirrhosis
Conditions: SBP;   Liver Cirrhosis
Interventions: Drug: Cefotaxime;   Drug: Ceftriaxone;   Drug: Ciprofloxacin
23 Recruiting Conservative Treatment Versus Elective Repair of Umbilical Hernia in Patients With Ascites and Liver Cirrhosis
Conditions: Umbilical Hernia;   Liver Cirrhosis;   Ascites
Interventions: Procedure: Conservative treatment;   Procedure: Surgical repair
24 Unknown  Autologous Bone Marrow Mononuclear Cells in Liver Cirrhosis
Condition: Liver Cirrhosis Due to Virus C Chronic Hepatitis
Intervention: Genetic: Autologous bone marrow mononuclear cells infusion
25 Recruiting Optimized Treatment and Regression of HBV-induced Early Cirrhosis
Condition: Liver Cirrhosis
Interventions: Drug: entecavir;   Drug: Thymosin-α
26 Unknown  Umbilical Cord Mesenchymal Stem Cells Infusion Via Hepatic Artery in Cirrhosis Patients
Conditions: Liver Cirrhosis;   Radiology;   Mesenchymal Stem Cells;   Umbilical Cord
Interventions: Biological: umbilical cord Mesenchymal Stem Cells;   Drug: Conserved therapy
27 Unknown  AFP - L3% and DCP as Screening Marker for a Hepatocellular Carcinoma in Patients With Cirrhosis of the Liver
Condition: Liver Cirrhosis
Intervention:
28 Recruiting Intestinal Decontamination With Rifaximin. The Inflammatory and Circulatory State in Patients With Cirrhosis
Conditions: Liver Cirrhosis;   Ascites
Interventions: Drug: Rifaximin;   Drug: placebo
29 Recruiting REVIVE(Randomized Exploratory Clinical Trial to Evaluate the Safety and Effectiveness of Stem Cell Product in Alcoholic Liver Cirrhosis Patient)
Condition: Alcoholic Liver Cirrhosis
Intervention: Biological: Livercellgram
30 Not yet recruiting Pilot Study Of The Effect Of Rifaximin On B-Cell Dysregulation In Cirrhosis
Conditions: Liver Cirrhosis;   Chronic Hepatitis C
Interventions: Drug: Rifaximin;   Drug: Placebo
31 Unknown  Human Albumin for the Treatment of Ascites in Patients With Hepatic Cirrhosis
Conditions: Liver Cirrhosis;   Ascites
Interventions: Drug: Diuretics plus human albumin;   Drug: Diuretics (standard medical treatment)
32 Unknown  Muscle Tissue Oxygenation in Patients With Decompensated Liver Cirrhosis
Condition: Liver Cirrhosis
Intervention:
33 Unknown  TCM Etiological Study on the Theory of XuSunShengJi in Liver Cirrhosis
Condition: Liver Cirrhosis
Intervention: Drug: Fuzhenghuayu Tablet, Huangqi Decoction Granule
34 Not yet recruiting Randomised Controlled Trial of Mechanistic Effects of Rifaximin in Cirrhosis and Chronic Hepatic Encephalopathy
Conditions: Liver Cirrhosis;   Hepatic Encephalopathy.
Intervention: Drug: Rifaximin-α
35 Unknown  Study of the Impact of Hypersplenism and Splenectomy on Hepatocarcinogenesis in Patients With Posthepatitic Cirrhosis
Conditions: Liver Cirrhosis;   Carcinoma, Hepatocellular;   Splenomegaly;   Laparotomy
Intervention:
36 Unknown  Bosentan for Treatment of Hepatopulmonary Syndrome in Patients With Liver Cirrhosis
Conditions: Hepatopulmonary Syndrome;   Liver Cirrhosis
Interventions: Drug: bosentan;   Drug: Placebo
37 Recruiting Dose-ranging Study of Rifaximin Soluble Solid Dispersion (SSD) Tablets for the Prevention of Complications of Early Decompensated Liver Cirrhosis
Condition: Liver Cirrhosis
Interventions: Drug: Placebo;   Drug: Rifaximin SSD 40 mg IR tablet;   Drug: Rifaximin SSD 80 mg IR tablet;   Drug: Rifaximin SSD 40 mg SER tablet;   Drug: Rifaximin SSD 80 mg SER tablet;   Drug: Rifaximin SSD 80 mg IR tablet + rifaximin SSD 80 mg SER tablet
38 Recruiting Validation of Child-Turcotte-Pugh-Kumar (CTPK) Score in Predicting Short Term Mortality in Patients With Liver Cirrhosis
Condition: Cirrhosis
Intervention:
39 Recruiting Evaluating Ultrasound, Elastometry, Minilaparoscopy and Histology for the Diagnosis of Compensated Liver Cirrhosis.
Condition: Cirrhosis
Intervention: Procedure: ultrasound, liver elastometry, minilaparoscopy
40 Recruiting Treatment of Liver Cirrhosis Due to Hepatitis B Virus With Fuzheng Huayu and Entecavir
Condition: Liver Cirrhosis Due to Hepatitis B Virus
Interventions: Drug: Entecavir + Fuzheng Huayu Tablet;   Drug: Entecavir + Placebo

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years